TILS.L Regulatory News (TILS)

20 May 2009 17:28



20th May 2009

REGEN THERAPEUTICS PLC 

("ReGen" or the "Company"; Ticker: (RGT))

TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES

Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

ReGen Therapeutics Plc

2. Reason for the notification:

An acquisition or disposal of voting rights 

3. Full name of person(s) subject to the notification obligation (iii):

Barclays PLC

4. Full name of shareholder(s) (if difference from 3):

Barclays Stockbrokers Ltd

5. Date of the transaction and date on which the threshold is crossed or reached (v):

18th May 2009

6. Date on which issued notified:

20th May 2009

7. Threshold(s) that is/are crossed or reached:

11% to 12%

8. Notified details 

A: Voting rights attached to shares

Class/type of share if possible using the ISIN Code GB00B28XMY25

Situation Previous to the triggering transaction (vi) -

Number of Shares 3,058,645

Number of Voting Rights (viii) 3,058,645

Resulting situation after the triggering transaction (viii) -

Number of Shares 3,072,491

Number of Voting Rights - Direct (x) N/A

Number of Voting Rights - Indirect (xi) 3,072,491

% of voting rights - Direct N/A

% of voting rights - Indirect 12.03

B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of financial instrument N/A

Expiration date (xiii) N/A

Exercise/Conversion Period/Date (xiv) N/A

Number of voting rights that may be acquired if the 

instrument is exercised/converted N/A

% of voting rights N/A

Total (A+B)

Number of voting rights 3,072,491

% of voting rights 12.03

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held,

if applicable (xv): Barclays Stockbrokers Ltd

Proxy Voting:

10. Name of the proxy holder: N/A

11. Number of voting rights proxy holder will cease to hold: N/A

12. Date on which proxy holder will cease to hold voting rights: N/A

13. Additional information: N/A

14. Contact name: Geoff Smith

15. Contact telephone number: 0207 116 2913

For further information:

For further information, please contact: Percy Lomax ReGen Therapeutics Plc Tel: 020 7153 4920 Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel: 020 7628 3396